Table 4.
Comparison of Characteristics of HCC patients in DAAs and PR groups.
| DAAs | PR | P value | |
|---|---|---|---|
| N | 29 | 25 | |
| Age (yr) | 58.0 ± 8.3 | 60.8 ± 7.8 | 0.215 |
| Male sex (n, %) | 14 (48.3) | 12 (48.0) | 1.000 |
| BMI (Kg/m2) | 24.4 ± 3.1 | 23.4 ± 3.3 | 0.273 |
| NAFLD (n, %) | 18 (62.1) | 7 (28.0) | 0.026 |
| Genotype (n, %) | 0.310 | ||
| 1b | 21 (72.4) | 22 (88.0) | |
| 2a | 7 (24.1) | 3 (12.0) | |
| Others | 1 (3.4) | 0 (0.0) | |
| BCLC (n, %) | 0.088 | ||
| 0 | 4 (13.8) | 6 (24.0) | |
| A | 10 (34.5) | 13 (52.0) | |
| B | 10 (34.5) | 6 (24.0) | |
| C | 5 (17.2) | 0 (0.0) | |
| Numbers of nodule (n) | 1.8 ± 1.2 | 1.6 ± 1.2 | 0.723 |
| Cancer treatment (n, %) | 0.021 | ||
| Resection | 8 (27.6) | 2 (8.0) | |
| Ablation | 7 (24.1) | 9 (36.0) | |
| TACE | 8 (27.6) | 6 (24.0) | |
| Liver transplantation | 4 (13.8) | 0 (0.0) | |
| Systematic therapy | 2 (6.9) | 8 (32.0) | |
| mRECIST (n, %) | 0.200 | ||
| CR | 15 (51.7) | 15 (60.0) | |
| PR | 5 (17.2) | 1 (4.0) | |
| SD | 2 (6.9) | 0 (0.0) | |
| PD | 7 (24.1) | 9 (36.0) | |
| Dead (n, %) | 5 (17.2) | 6 (24.0) | 0.782 |
| Follow-up time (months) | 19.0 (13.0–23.5) | 19.2 (14.9–24.5) | 0.815 |
Continuous variables were expressed as mean ± sd or median (IQR) and compared using the unpaired, 2-tailed t-test or Mann-Whitney test. Categorical variables were presented as numbers (percentages) and compared using the chi-square test. CR, complete response; PR, partial response; PD, progressive disease; SD, stable disease.